SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
jessia
Lv2
158 积分
2021-08-23 加入
最近求助
最近应助
互助留言
Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer
1天前
待确认
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial
6天前
已完结
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
6天前
已完结
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
6天前
已完结
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
6天前
已完结
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer
9天前
已完结
Extensive-stage small-cell lung cancer: Current management and future directions
22天前
已完结
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
22天前
已完结
Lurbinectedin: A New Treatment Option for Relapsed/Refractory Small-Cell Lung Cancer
22天前
已完结
Lurbinectedin
22天前
已关闭
没有进行任何应助
已检索到【积分已退回】
1个月前
感谢,点赞
2年前
点赞,感谢
2年前
速度真快,点赞
2年前
谢谢!么么哒
2年前
感谢,帮大忙了,么么哒
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论